Dr. Leon Barkodar, MD

Dr. Barkodar practices at Valley Surgical Center LLC in West Hills, California.

Dr. Barkodar's NPI, 1760700496, was assigned on May 5, 2010. Dr. Barkodar graduated from Lewis Katz School of Medicine in 2010. Dr. Barkodar's California license number on file is A120910.

Dr. Barkodar's primary practice is Valley Surgical Center LLC, at 7320 N Woodlake Ave, West Hills, CA 91307 in Los Angeles County. The practice phone is (818) 610-3966.

Dr. Barkodar's primary practice is Valley Surgical Center LLC in West Hills, California. Dr. Barkodar is also affiliated with UCLA West Valley Medical Center. The medical group on file is Neurology Los Angeles. Dmand AI also links Dr. Barkodar to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barkodar practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Barkodar's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Barkodar is board certified in brain injury medicine by the American Board of Psychiatry and Neurology. Dr. Barkodar has a license on file in California.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, encephalopathy, epilepsy, essential tremor, fibromyalgia and chronic pain and hereditary polyneuropathy among the conditions Dr. Barkodar treats.

CMS data shows 927 Medicare services from Dr. Barkodar across 6 procedure codes in 2024, for 412 Medicare patients. Medicare paid $137,307 for them. Every service was in an office.

CMS counts 412 Medicare patients who saw Dr. Barkodar in 2024. The largest group is 75 to 84, with 172 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barkodar's median patient age at 63, with 63% women.

In 2024, Dr. Barkodar wrote 3,608 Medicare Part D claims for 560 patients. 91% of them were for generic drugs. CMS names the drug for 3,277 of them, across 59 drugs with 11 or more claims each, at $336,238 in total drug cost. In 2023, CMS named 3,744 claims across 68 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Barkodar for performance year 2024, reported individually. Dr. Barkodar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Barkodar as offering telehealth.

Dmand AI links Dr. Barkodar to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Pick Disease of the Brain, Plaque, Amyloid and Cognitive Dysfunction. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Barkodar that name 2 trials.

CMS Open Payments shows 259 general payments to Dr. Barkodar from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Abbvie Inc. paid the most, $10,218. It also lists 5 research payments totaling $13,268 from 2022 to 2024, naming 2 clinical trials.

Dr. Barkodar graduated from Lewis Katz School of Medicine in 2010.

Dr. Barkodar is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.